Ashish Jha served as the Biden administration's COVID response coordinator and founded a company focused on detecting emerging biological threats. He has publicly warned that minor technical changes in gene therapy research could produce more harmful pathogens and that accidental releases from deliberate lab programs represent the primary risk. Available reporting on these statements comes exclusively from left-center sources, limiting the range of examined viewpoints.